CPE at the World Cancer Congress 2026
From 24–26 September 2026, CPE joined the World Cancer Congress 2026 in Hong Kong, organised by the Union for International Cancer Control (UICC) and… Read More
CPE Launches Policy Statement on Most Favoured Nation Drug Pricing
CPE has published its Policy Statement "Most Favoured Nation Drug Pricing: Ensuring Patient Access to Innovation in Europe" and is now inviting organisations across Europe to… Read More
CPE Co-Authors Joint Stakeholder Statement on the First Joint Clinical Assessment Report
CPE has joined a coalition focused on the advanced therapies and rare diseases, including patient organisations, clinicians, medical societies, academic centres and therapy developers, in endorsing a joint… Read More
Putting Patients at the Heart of Research: CPE Leads Seminar for Clinicians and Researchers
On 15 June 2026, our Research and Patient Engagement Director, Juan-José Ventura, led Seminar 7: Patient Engagement in Research — An Introduction for Clinicians &… Read More
CPE joins call for France to make antimicrobial resistance a G7 priority
As G7 leaders gathered in Evian from 15 to 17 June, CPE joined around 60 experts — clinicians, researchers, patient organisations and industry partners — in an open… Read More
Momentum 2026 – Accelerating Europe’s action on cancer
Momentum is a European high-level cancer conference organised by the Swedish Cancer Society and endorsed by us at Cancer Patients Europe, together with the… Read More
CPE at ESTRO 2026: Championing Patient-Centred Innovation in Radiation Oncology
On 15-19 May 2026 CPE joined the Annual ESTRO Congress - “Innovating Radiation Oncology, Together” in Stockholm, Sweden. ESTRO is the Europe's leading radiation oncology event, showcasing and learn from… Read More
CPE Brings the Patient Voice to the JANE‑2 Network of Expertise on Personalised Prevention
On 11-12 May 2026, CPE CEO Antonella Cardone took part in the Network of Expertise in Personalised Prevention (WP8) in‑person meeting held in São Miguel, Azores. The meeting is part of JANE-2, an EU Joint… Read More
CPE at the SANOFI Co-Lab Annual Meeting 2026
On 22–23 April 2026 in Paris, Antonella Cardone, CPE CEO, participated in the Sanofi Co-Lab Annual Meeting. The Sanofi Co-Lab Annual Meeting brings together representatives from patient organisations worldwide… Read More
CPE at the CSO Annual Leadership Meeting
On 14-15 April 2026, Antonella Cardone, CPE CEO, participated in the Annual Leadership Meeting by Common Sense Oncology in Montreal, Canada. The meeting gathered global leaders from across oncology,… Read More